AusBiotech proudly welcomed a significant number of new members.Our latest members span biotechnology, medical ...

Debiopharm further describes AbYlink as a one-step method that results in stable conjugation at defined and invariable sites on the Fc domain of an antibody, with no impact on antigen-binding regions, ...

The University of Queensland will play a key role in a national effort to revolutionize treatment for men with prostate cancer.

In a Linkedin post early this month, Bedrock Materials CEO Spencer Gore announced he was shutting down less than two years ...

The company’s strong financials and innovative collaborations, such as its partnership with AdvanCell to develop targeted cancer therapies, further enhance its appeal.

On February 10, the company announced a collaboration with AdvanCell to advance cancer treatment through targeted alpha therapies. By combining Eli Lilly and Company’s (NYSE:LLY) expertise in drug ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best ...

The latest Cut Through Ventures startup funding report shows AI deals dominated Q1 of 2025. But there's a good reason for that.

Cancer treatment start-up AdvanCell’s raised $171 million and Aravax raised $66 million to help grow its allergy symptom reduction products. The average deal size rose to an all-time high over ...

SYDNEY--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced $18M in Australian Federal Government Funding from the ...